The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response said today it has awarded a $1.8 million contract to OraSure Technologies Inc., in Bethlehem, PA, to develop an Ebola virus diagnostic test for use in a doctor’s office, hospital, clinic or field setting that will provide results within 20 minutes. Called the OraQuick rapid Ebola antigen test, HHS said the lateral-flow test will detect the presence of a virus with a drop of the patient’s blood or saliva on a test strip, similar to tests used in doctors’ offices to diagnose strep throat. The contract could be extended for up to 39 months and $10.4 million.